| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.03. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 438 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 58 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 10.02. | Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition | 1 | GlobeNewswire (USA) | ||
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 405 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 387 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 04.12.25 | Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview | 1 | GlobeNewswire (USA) | ||
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 435 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 318 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 468 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 596 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 422 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 462 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 442 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 364 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 502 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09.25 | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 514 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen | |
| 25.06.25 | Marijuana Inc.: Exousia Pro Files Reg A. | 312 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of... ► Artikel lesen | |
| 18.06.25 | Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board | 653 | ACCESS Newswire | Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company... ► Artikel lesen | |
| 30.04.25 | Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant | 346 | ACCESS Newswire | Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 210,40 | +0,19 % | EQS-News: SARTORIUS AG: Sartorius schärft Strategie mit Fokus auf Biopharma und setzt neue mittelfristige Wachstumsziele | EQS-News: SARTORIUS AG
/ Schlagwort(e): Prognose/Kapitalmarkttag
Sartorius schärft Strategie mit Fokus auf Biopharma und setzt neue mittelfristige Wachstumsziele (News mit Zusatzmaterial)
17.03.2026... ► Artikel lesen | |
| DRONESHIELD | 2,200 | -4,97 % | Drohnen-Krieg wird zum NATO-Thema! Airbus, NEO Battery Materials und DroneShield im Fokus | So schnell wie der US-Präsident den "Sondereinsatz Iran" durchführen wollte, klappt es dann doch nicht. Anfang März starteten die Luftangriffe auf den persischen Staat, seither geht es an den Börsen... ► Artikel lesen | |
| PVA TEPLA | 30,020 | -1,64 % | Crash voraus: Micron: Capex zu hoch, Vonovia: Zinsangst & PVA Tepla: Volle Auftragsbücher | Speicherspezialist Micron hat Zahlen wie aus dem Bilderbuch vorgelegt. Die Aktie rutscht trotzdem ab. Die Investitionsausgaben scheinen den Anlegern zu hoch zu sein. Ist die Sorge berechtigt oder ergibt... ► Artikel lesen | |
| SERVE ROBOTICS | 9,430 | 0,00 % | Serve Robotics stock price target lowered to $16 by Cantor Fitzgerald | ||
| GPGI | 17,640 | 0,00 % | GPGI, Inc.: GPGI Reports Strong Fourth Quarter with Organic Revenue Growth of 17%, Net Income Growth of 189%, and Pro Forma Adjusted EBITDA Growth of 41% | Fourth Quarter 2025Results compared to prior year period unless otherwise noted; does not include results for Husky Technologies Non-GAAP Net Sales of $118 million, up 17%GAAP Net Income of $43... ► Artikel lesen | |
| UNUSUAL MACHINES | 15,990 | 0,00 % | Unusual Machines, Inc.: Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock | ORLANDO, FL / ACCESS Newswire / March 20, 2026 / Unusual Machines, Inc. (NYSE American:UMAC), (the "Company", or "Unusual Machines"), a United States-based manufacturer and distributor of drone parts... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 5,855 | 0,00 % | Evolv Technology expands screening contract with Houston Astros | ||
| 2G ENERGY | 32,750 | -4,24 % | Heißer als die Wasserstoffaktien Nel ASA und Plug Power: Die diskreten Krisengewinner CHAR Technologies, 2G Energy und Verbio! | Die politisch gewollte Energiewende sollte so einiges verändern, doch während viele noch über ferne Träume diskutieren, schaffen drei Unternehmen bereits heute knallharte Fakten. Es geht um mehr als... ► Artikel lesen | |
| INNOVATIVE SOLUTIONS & SUPPORT | 29,910 | 0,00 % | IS&S Rebrands to Innovative Aerosystems | New brand identity reflects focus on integrating advanced avionics with intelligent system designs to deliver innovative aerospace solutions
EXTON, Pa.--(BUSINESS WIRE)--Innovative Solutions & Support... ► Artikel lesen | |
| PARROT | 9,840 | -5,38 % | PARROT: First NATO Support and Procurement Agency (NSPA) call-off orders placed for Parrot ANAFI UKR micro-UAV systems | First NATO Support and Procurement Agency (NSPA) call-off orders placed for Parrot ANAFI UKR micro-UAV systems
Parrot, a European leader in professional micro-UAVs, has announced that initial call-off... ► Artikel lesen | |
| TKH GROUP | 37,240 | +1,25 % | TKH Group N.V.: Full year 2025 and Q4 2025 results - TKH delivers strong Q4 | Highlights fourth quarter 2025
• Turnover increased by 8.7% organically to €483.7 million
• Added value of 52.4%
• Adjusted EBITA increased by 8.1% organically to €70.5 million with a substantial... ► Artikel lesen | |
| PFEIFFER VACUUM TECHNOLOGY | 163,60 | +0,12 % | EQS-PVR: Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Pfeiffer Vacuum Technology AG
Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading... ► Artikel lesen | |
| KRATOS DEFENSE | 70,46 | -3,87 % | Kratos Defense & Security Solutions, Inc.: Kratos Selected by SKY Perfect JSAT as Strategic Partner for 5G NTN Satellite Ground System | SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company specializing in Defense, National Security and Global Markets, today announced... ► Artikel lesen | |
| KLA | 1.294,40 | +0,08 % | Jim Cramer Recommended Putting KLA (KLAC) "in the Drawer" In February 2025 | ||
| CODA OCTOPUS | 12,050 | 0,00 % | Coda Octopus Group, Inc.: Coda Octopus Group Reports Fiscal First Quarter 2026 Financial Results | ORLANDO, FL, March 17, 2026 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. ("CODA" or the "Company") (Nasdaq: CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology for real-time... ► Artikel lesen |